Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Clinical Needs of Patients with Problem Drug Use

Antoinette Krupski, Imara I. West, Meredith C. Graves, David C. Atkins, Charles Maynard, Kristin Bumgardner, Dennis Donovan, Richard Ries and Peter Roy-Byrne
The Journal of the American Board of Family Medicine September 2015, 28 (5) 605-616; DOI: https://doi.org/10.3122/jabfm.2015.05.150004
Antoinette Krupski
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imara I. West
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meredith C. Graves
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Atkins
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Maynard
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Bumgardner
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennis Donovan
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Ries
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Roy-Byrne
From the Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington at Harborview Medical Center, Seattle (AK, IIW, MCG, DCA, KB, DD, RR, PR-B); the Department of Health Services, University of Washington School of Public Health, Seattle (CM); and the Alcohol & Drug Abuse Institute, University of Washington, Seattle (DD).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    National Drug Intelligence Center. The economic impact of illicit drug use on American society. Washington, DC: US Department of Justice; 2011.
  2. 2.↵
    1. Compton WM,
    2. Thomas YF,
    3. Stinson FS,
    4. Grant BF
    . Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2007;64:566–76.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Mertens JR,
    2. Lu YW,
    3. Parthasarathy S,
    4. Moore C,
    5. Weisner CM
    . Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med 2003;163:2511–7.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Regier DA,
    2. Farmer ME,
    3. Rae DS,
    4. et al
    . Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–8.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Onyeka IN,
    2. Beynon CM,
    3. Uosukainen H,
    4. et al
    . Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: the HUUTI study. BMC Public Health 2013;13:380.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Deck D,
    2. Wiitala W,
    3. McFarland B,
    4. et al
    . Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states. J Addict Dis 2009;28:89–8102.
    OpenUrlPubMed
  7. 7.↵
    1. Nardone M,
    2. Snyder S,
    3. Paradise J
    . Integrating physical and behavioral health care: promising medicaid models. Menlo Park (CA): Kaiser Family Foundation; 2014.
  8. 8.↵
    1. Blow FC,
    2. Walton MA,
    3. Barry KL,
    4. et al
    . Alcohol and drug use among patients presenting to an inner-city emergency department: a latent class analysis. Addict Behav 2011;36:793–800.
    OpenUrlPubMed
  9. 9.↵
    1. Roy-Byrne P,
    2. Bumgardner K,
    3. Krupski A,
    4. et al
    . Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial. JAMA 2014;312:492–501.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Krupski A,
    2. Joesch JM,
    3. Dunn C,
    4. et al
    . Testing the effects of brief intervention in primary care for problem drug use in a randomized controlled trial: rationale, design, methods. Addict Sci Clin Pract 2012;7:27.
    OpenUrlPubMed
  11. 11.↵
    1. Skinner HA
    . The drug abuse screening test. Addict Behav 1982;7:363–71.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    1. Skinner HA
    . Guide for using the Drug Abuse Screening Test (DAST). 1982. Available from: http://www.emcdda.europa.eu/attachements.cfm/att_61480_EN_DAST%202008.pdf. Accessed September 2, 2014.
  13. 13.↵
    1. Cacciola JS,
    2. Alterman AI,
    3. McLellan AT,
    4. Lin YT,
    5. Lynch KG
    . Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend 2007;87:297–302.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Alterman AI,
    2. McLellan AT,
    3. Shifman RB
    . Do substance abuse patients with more psychopathology receive more treatment? J Nerv Ment Dis 1993;181:576–82.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Cacciola JS,
    2. Alterman AI,
    3. Lynch KG,
    4. Martin JM,
    5. Beauchamp ML,
    6. McLellan AT
    . Initial reliability and validity studies of the revised Treatment Services Review (TSR-6). Drug Alcohol Depend 2008;92:37–47.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Hall SM,
    2. Havassy BE,
    3. Wasserman DA
    . Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol 1990;58:175–81.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Darke S,
    2. Hall W,
    3. Heather N,
    4. Ward J,
    5. Wodak A
    . The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS 1991;5:181–5.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Kronick R,
    2. Gilmer T,
    3. Dreyfus T,
    4. Lee L
    . Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev 2000;21:29–64.
    OpenUrlPubMedWeb of Science
  19. 19.↵
    1. McLellan AT,
    2. Cacciola JC,
    3. Alterman AI,
    4. Rikoon SH,
    5. Carise D
    . The Addiction Severity Index at 25: origins, contributions and transitions. Am J Addict 2006;15:113–24.
    OpenUrlPubMed
  20. 20.
    1. Cacciola JS,
    2. Pecoraro A,
    3. Alterman AI
    . Development of ASI psychiatric severity cut-off scores to identify co-occurring psychiatric disorders. Int J Ment Health Addiction 2008;6:77–92.
    OpenUrl
  21. 21.↵
    1. West S,
    2. O'Neal K,
    3. Graham C
    . A meta-analysis comparing the effectiveness of buprenorphine and methadone. J Subst Abuse 2000;12:405–14.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Archer J,
    2. Bower P,
    3. Gilbody S,
    4. et al
    . Collaborative care for depression and anxiety problems. Cochrane Database Syst Rev 2012;10:CD006525.
    OpenUrlPubMed
  23. 23.↵
    1. Chan YF,
    2. Huang H,
    3. Bradley K,
    4. Unutzer J
    . Referral for substance abuse treatment and depression improvement among patients with co-occurring disorders seeking behavioral health services in primary care. J Subst Abuse Treat 2014;46:106–12.
    OpenUrlPubMed
  24. 24.↵
    1. Bauer AM,
    2. Azzone V,
    3. Goldman HH,
    4. et al
    . Evaluating the implementation of collaborative depression management in community-based primary care clinics. Psychiatr Serv 2011;62:1047–53.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Baird M,
    2. Blount A,
    3. Brungardt S,
    4. et al
    . The development of joint principles: integrating behavioral health care into the patient-centered medical home. Ann Fam Med 2014;12:183.
    OpenUrlFREE Full Text
  26. 26.↵
    Working Party Group on Integrated Behavioral Healthcare. The development of joint principles: integrating behavioral health care into the patient-centered medical home. Fam Syst Health 2014;32:153.
    OpenUrlPubMed
  27. 27.↵
    1. Kessler R,
    2. Miller BF,
    3. Kelly M,
    4. et al
    . Mental health, substance abuse, and health behavior services in patient-centered medical homes. J Am Board Fam Med 2014;27:637–44.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Humeniuk R
    . Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction 2008;103:1039–47.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 28 (5)
The Journal of the American Board of Family Medicine
Vol. 28, Issue 5
September-October 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Needs of Patients with Problem Drug Use
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Needs of Patients with Problem Drug Use
Antoinette Krupski, Imara I. West, Meredith C. Graves, David C. Atkins, Charles Maynard, Kristin Bumgardner, Dennis Donovan, Richard Ries, Peter Roy-Byrne
The Journal of the American Board of Family Medicine Sep 2015, 28 (5) 605-616; DOI: 10.3122/jabfm.2015.05.150004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Clinical Needs of Patients with Problem Drug Use
Antoinette Krupski, Imara I. West, Meredith C. Graves, David C. Atkins, Charles Maynard, Kristin Bumgardner, Dennis Donovan, Richard Ries, Peter Roy-Byrne
The Journal of the American Board of Family Medicine Sep 2015, 28 (5) 605-616; DOI: 10.3122/jabfm.2015.05.150004
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Successful Implementation of Integrated Behavioral Health
  • Identifying and Addressing Social Determinants of Health with an Electronic Health Record
  • Integrating Adverse Childhood Experiences and Social Risks Screening in Adult Primary Care
Show more Original Research

Similar Articles

Keywords

  • Comorbidity
  • Delivery of Health Care
  • Integrated
  • Drug Abuse
  • Health Care Costs
  • Primary Health Care

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire